A new article from MDDIonline.com says “These days, it often seems the main struggle for medical device companies is not earning FDA regulatory clearance, but rather, securing reimbursement from CMS and private payers. With that in mind, there are few in the...
FDANews.com released a statement that “Abbott Laboratories announced its purchase of Tendyne Holdings Inc., a medical device company focused on developing minimally invasive mitral valve replacement therapies, for $250 million plus potential future payments tied...
The FDA has recently approved a new device to assist with extreme weight loss, according to EverydayHealth.com. “The U.S. Food and Drug Administration on Tuesday approved a temporary, implanted balloon device to treat obesity. The ReShape Integrated Dual...
Miss out on the 4th Annual Strengthening Patient Advocacy Relations Conference? Take a look at some of the highlights from delegates, sponsors, and speakers on social media